These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 26485709

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The natural flavonoid apigenin sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy.
    Erdogan S, Turkekul K, Serttas R, Erdogan Z.
    Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Trabectedin in soft tissue sarcomas.
    Brodowicz T.
    Future Oncol; 2014 Jun; 10(8 Suppl):s1-5. PubMed ID: 25048043
    [Abstract] [Full Text] [Related]

  • 30. Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53.
    Hu B, Shen KP, An HM, Wu Y, Du Q.
    Cancer Biother Radiopharm; 2011 Feb; 26(1):97-104. PubMed ID: 21348775
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models.
    Martinez-Cruzado L, Tornin J, Rodriguez A, Santos L, Allonca E, Fernandez-Garcia MT, Astudillo A, Garcia-Pedrero JM, Rodriguez R.
    Neoplasia; 2017 Jun; 19(6):460-470. PubMed ID: 28494349
    [Abstract] [Full Text] [Related]

  • 35. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
    Howard EW, Lee DT, Chiu YT, Chua CW, Wang X, Wong YC.
    Int J Cancer; 2008 May 01; 122(9):1941-8. PubMed ID: 18183597
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem.
    Cuevas C, Francesch A.
    Nat Prod Rep; 2009 Mar 01; 26(3):322-37. PubMed ID: 19240944
    [Abstract] [Full Text] [Related]

  • 38. Unique features of trabectedin mechanism of action.
    Larsen AK, Galmarini CM, D'Incalci M.
    Cancer Chemother Pharmacol; 2016 Apr 01; 77(4):663-71. PubMed ID: 26666647
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis.
    Xiao D, Srivastava SK, Lew KL, Zeng Y, Hershberger P, Johnson CS, Trump DL, Singh SV.
    Carcinogenesis; 2003 May 01; 24(5):891-7. PubMed ID: 12771033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.